China Cord Blood Corp  

(Public, NYSE:CO)   Watch this stock  
Find more results for CO
+0.08 (1.44%)
Mar 27 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 5.54 - 5.87
52 week 3.98 - 6.70
Open 5.54
Vol / Avg. 81,209.00/162,704.00
Mkt cap 406.71M
P/E 21.30
Div/yield     -
EPS 0.27
Shares 73.00M
Beta 1.06
Inst. own 31%
Feb 26, 2015
Q3 2015 China Cord Blood Corp Earnings Call - Webcast
Feb 25, 2015
Q3 2015 China Cord Blood Corp Earnings Release
Jan 14, 2015
China Cord Blood Corp at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2014
Net profit margin 19.30% 23.13%
Operating margin 39.24% 40.49%
EBITD margin - 46.96%
Return on average assets 3.22% 4.01%
Return on average equity 8.21% 8.75%
Employees 944 -
CDP Score - -


48th Floor, Bank of China Tower 1 Garden Road, Central
Hong Kong S.A.R.,
Hong Kong
+85236058180 (Phone)
+85236058181 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


China Cord Blood Corporation (CCBC) is a provider of cord blood storage and ancillary services. The Company is engaged in the provision of umbilical cord blood storage and ancillary services in its cord blood banks in the People�s Republic of China (PRC). The Company provides cord blood storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants. It also tests; processes and stores donated cord blood, and provides matching services to the public.

Officers and directors

Yuen Kam Chairman of the Board
Age: 52
Bio & Compensation  - Reuters
Ting Zheng Chief Executive Officer, Director
Age: 41
Bio & Compensation  - Reuters
Albert Chen Chief Financial Officer, Director
Age: 37
Bio & Compensation  - Reuters
Rui Arashiyama Chief Executive Officer - Guangdong and Zhejiang Divisions
Age: 54
Bio & Compensation  - Reuters
Yue Deng Chief Executive Officer - Beijing Division
Age: 43
Bio & Compensation  - Reuters
Xin Xu Chief Technology Officer
Age: 59
Bio & Compensation  - Reuters
Mark D. Chen Non-Executive Independent Director
Age: 46
Bio & Compensation  - Reuters
Ken Lu Non-Executive Independent Director
Age: 51
Bio & Compensation  - Reuters
Jennifer J. Weng Non-Executive Independent Director
Age: 45
Bio & Compensation  - Reuters
Julian J. Wolhardt CPA Independent Non-executive Director
Age: 41
Bio & Compensation  - Reuters